Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal Midazolam as Adjuvant to Bupivacaine in Children
NCT04718259Phase 1Completed
- Sponsor
- Tanta University
- Start
- Jan 2020
- Primary completion
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of midazolam in postoperative pain (2 arms), sponsored by Tanta University. Primary endpoints: Duration of postoperative analgesia at 90 days, Duration of analgesia at 90 days and 3 more. Started Jan 2020; status: completed.
02
Drugs
midazolam
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04718259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04718259.